| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 7, 2007
From the Division of Cardiology, Department of Internal Medicine (C.-T.T., L.-P.L., J.-J.H., C.-S.H., K.-L.H., C.-D.T., Y.-Z.T., J.-L.L.), Department of Pathology (K.-T.K.), and Department of Laboratory Medicine (F.-T.C.), National Taiwan University Hospital, Taipei, Taiwan, and Institute of Pharmacology (L.-P.L.), National Taiwan University, Taipei, Taiwan. * To whom correspondence should be addressed. E-mail: lplai2003{at}ntu.edu.tw.
Background—Recently, activation of the local renin-angiotensin system and mitogen-activated protein kinase pathways in atrial myocardium has been found to play an important role in atrial structural remodeling related to atrial fibrillation. Another important mediator of the angiotensin II (Ang II) effect is the Janus kinase/signal transducers and activators of transcription (STAT) pathway, which has never been characterized in the atrium. Methods and Results—In cultured atrial myocytes and fibroblasts, Ang II induced tyrosine phosphorylation of STAT3 through a Rac1-dependent mechanism, which was inhibited by dominant-negative Rac1, losartan, and simvastatin. In atrial myocytes, activation of STAT3 by Rac1 was mediated by direct association of Rac1 with STAT3; however, in atrial fibroblasts, it was mediated by an indirect paracrine effect. Constitutively active STAT3 increased protein synthesis, and dominant-negative STAT3 abrogated Ang II–induced protein synthesis in atrial myocytes and fibroblasts. Rats infused long term with Ang II exhibited higher levels of activated Rac1, phospho-STAT3, collagen synthesis, and atrial fibrosis in the atria, all of which were attenuated by oral losartan and simvastatin. In human atrial tissues from patients with atrial fibrillation, Ang II and phospho-STAT3 levels were also elevated. Conclusions—The Ang II/Rac1/STAT3 pathway is an important signaling pathway in the atrial myocardium to mediate atrial structural remodeling, and losartan and statin may be able to reverse Ang II–induced atrial structural remodeling in atrial fibrillation.
Accepted on October 26, 2007
Angiotensin II Activates Signal Transducer and Activators of Transcription 3 via Rac1 in Atrial Myocytes and Fibroblasts. Implication for the Therapeutic Effect of Statin in Atrial Structural Remodeling
Chia-Ti Tsai MD, PhD,
Related Article:
Circulation 2008 117: 331-332.
This article has been cited by other articles:
![]() |
C.-T. Tsai, L.-P. Lai, J.-J. Hwang, J.-L. Lin, and F.-T. Chiang Molecular Genetics of Atrial Fibrillation J. Am. Coll. Cardiol., July 22, 2008; 52(4): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hilfiker-Kleiner and R. Knoll Disease-Modifying Mutations in Familial Hypertrophic Cardiomyopathy: Complexity From Simplicity Circulation, April 8, 2008; 117(14): 1775 - 1777. [Full Text] [PDF] |
||||
![]() |
M. C. Simeone-Penney, M. Severgnini, L. Rozo, S. Takahashi, B. H. Cochran, and A. R. Simon PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1 Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L698 - L704. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |